文献速递胃肠动力与功能性疾病

Brachyspira定植与腹泻型肠易激综合征相关

Association between Brachyspira and irritable bowel syndrome with diarrhoea.
PubMed 文献 · Gut · 2020-11-11

研究采用宏蛋白质组学分析结肠黏液样本,发现部分IBS患者存在潜在致病性Brachyspira属定植。在两个前瞻队列中,IBS患者黏膜Brachyspira定植率为19/62(31%),健康志愿者为0/31(p<0.001);腹泻型IBS(IBS-D)定植率两队列均为40%。Brachyspira附着于结肠细胞顶膜与传输加速、轻度黏膜炎症、肥大细胞活化及分子通路改变相关,提示其可能参与IBS尤其IBS-D的发病。

要点

  • IBS患者黏膜Brachyspira定植率31%,健康志愿者0%(p<0.001)。
  • IBS-D患者定植率两队列均为40%,与对照组差异显著。
  • Brachyspira附着与传输加速、轻度炎症及肥大细胞活化相关。

核心结论

  • 黏膜Brachyspira定植在IBS中显著更常见,并与独特的临床、组织学和分子特征相关,提示其可能参与IBS尤其IBS-D的发病。

研究设计与样本

  • 前瞻性收集IBS患者和健康志愿者乙状结肠活检的黏液样本,用质谱分析微生物蛋白质组成。
  • 通过免疫荧光、电镜和实时PCR验证观察,并在第二队列中进一步确认,同时与临床特征和黏膜免疫反应关联分析。

主要发现

  • 宏蛋白质组学在部分IBS患者结肠黏液样本中鉴定出潜在致病性Brachyspira属的肽段。
  • 两个前瞻队列中IBS患者黏膜Brachyspira定植共19/62(31%),健康志愿者0/31(p<0.001)。
  • IBS-D患者Brachyspira定植率两个队列均为40%(p=0.02和p=0.006 vs 对照组)。
  • 20%的IBS患者观察到Brachyspira附着于结肠细胞顶膜,与口-肛传输加速、轻度黏膜炎症、肥大细胞活化及细菌摄取和离子-液体稳态相关分子通路改变有关。
  • 甲硝唑治疗反而促使Brachyspira转移至杯状细胞分泌颗粒,可能代表一种新的细菌逃逸抗生素策略。

临床怎么用

  • 对IBS-D患者可考虑评估黏膜Brachyspira定植,尤其当存在传输加速或轻度黏膜炎症时。
  • 甲硝唑可能促使Brachyspira进入杯状细胞分泌颗粒,临床用药需注意此现象。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The incidence of IBS increases following enteric infections, suggesting a causative role for microbial imbalance. However, analyses of faecal microbiota have not demonstrated consistent alterations. Here, we used metaproteomics to investigate potential associations between mucus-resident microbiota and IBS symptoms. DESIGN: Mucus samples were prospectively collected from sigmoid colon biopsies from patients with IBS and healthy volunteers, and their microbial protein composition analysed by mass spectrometry. Observations were verified by immunofluorescence, electron microscopy and real-time PCR, further confirmed in a second cohort, and correlated with comprehensive profiling of clinical characteristics and mucosal immune responses. RESULTS: Metaproteomic analysis of colon mucus samples identified peptides from potentially pathogenic Brachyspira species in a subset of patients with IBS. Using multiple diagnostic methods, mucosal Brachyspira colonisation was detected in a total of 19/62 (31%) patients with IBS from two prospective cohorts, versus 0/31 healthy volunteers (p<0.001). The prevalence of Brachyspira colonisation in IBS with diarrhoea (IBS-D) was 40% in both cohorts (p=0.02 and p=0.006 vs controls). Brachyspira attachment to the colonocyte apical membrane was observed in 20% of patients with IBS and associated with accelerated oro-anal transit, mild mucosal inflammation, mast cell activation and alterations of molecular pathways linked to bacterial uptake and ion-fluid homeostasis. Metronidazole treatment paradoxically promoted Brachyspira relocation into goblet cell secretory granules-possibly representing a novel bacterial strategy to evade antibiotics. CONCLUSION: Mucosal Brachyspira colonisation was significantly more common in IBS and associated with distinctive clinical, histological and molecular characteristics. Our observations suggest a role for Brachyspira in the pathogenesis of IBS, particularly IBS-D.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Jabbar KS, Dolan B, Eklund L, et al. Association between Brachyspira and irritable bowel syndrome with diarrhoea. Gut. 2020. PMID: 33177165. doi:10.1136/gutjnl-2020-321466

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。